Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Filed May 10, 2019 · 10-Q · 40 days after period end · 0001144204-19-025316
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Net Income | -$5.32M | -$3.20M | -$2.42M | -$4.75M |
| EPS Diluted | -$0.12 | -$0.30 | -$0.29 | -$0.81 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 10, 2019 · 40 d after period end
